Myriad Genetics Says US Patent And Trademark Office Has Granted Patent That Covers Use Of Push-Button Blood Collection Devices For PCR-Based Fetal Sex Determination
Myriad Genetics Says US Patent And Trademark Office Has Granted Patent That Covers Use Of Push-Button Blood Collection Devices For PCR-Based Fetal Sex Determination
Myriad Genetics表示，美国专利商标局已授予专利，涵盖使用按钮式血液采集设备进行基于PCR的胎儿性别测定
U.S. Patent No. 11,932,907, titled Fetal Sex Determination Using Capillary Blood From Upper Arm, provides protection for Myriad's SneakPeek Snap products in the U.S through 2040.
美国专利号 11,932,907，标题为 使用上臂毛细血管血确定胎儿的性别， 在 2040 年之前为美国的 Myriad 的 SneakPeek Snap 产品提供保护。